Publications by authors named "Natalia Cameron Ruiz"

Spillover events of avian influenza A viruses (IAVs) to humans could represent the first step in a future pandemic. Several factors that limit the transmission and replication of avian IAVs in mammals have been identified. There are several gaps in our understanding to predict which virus lineages are more likely to cross the species barrier and cause disease in humans.

View Article and Find Full Text PDF

Infected hosts possess two alternative strategies to protect themselves against the negative impact of virus infections: resistance, used to abrogate virus replication, and disease tolerance, used to avoid tissue damage without controlling viral burden. The principles governing pathogen resistance are well understood, while less is known about those involved in disease tolerance. Here, we studied bluetongue virus (BTV), the cause of bluetongue disease of ruminants, as a model system to investigate the mechanisms of virus-host interactions correlating with disease tolerance.

View Article and Find Full Text PDF

Inherited genetic factors can influence the severity of COVID-19, but the molecular explanation underpinning a genetic association is often unclear. Intracellular antiviral defenses can inhibit the replication of viruses and reduce disease severity. To better understand the antiviral defenses relevant to COVID-19, we used interferon-stimulated gene (ISG) expression screening to reveal that 2′-5′-oligoadenylate synthetase 1 (OAS1), through ribonuclease L, potently inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

View Article and Find Full Text PDF
Article Synopsis
  • The emergence of SARS-CoV-2 has triggered a global pandemic, prompting labs to focus on developing tools for SARS-CoV-2 research.
  • A new single plasmid reverse genetics system allows for easy genetic manipulation of the virus and rescue of infectious samples, supported by a comprehensive panel of antibodies and cell lines.
  • These resources enable research into viral proteins and antiviral strategies, potentially aiding in COVID-19 vaccine and drug development.
View Article and Find Full Text PDF